HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Burberry boosts IPAR sales In Q3

This article was originally published in The Rose Sheet

Executive Summary

Coming off a record-setting second quarter, Inter Parfums sales in the third quarter reached $120.9 mil., a 2.8% increase, firm reports Oct. 26. New launches earlier in the year, including Van Cleef & Arpels' Midnight in Paris for men and Oriens for women, along with Lanvin Marry Me, contributed to gains and drove net sales for the first nine months of 2010 up 17.3% to a record $348 mil. Burberry fragrance sales are up 18% year-to-date, with Burberry cosmetics and the global rollout of Burberry Sport contributing to the push. Inter Parfums is preparing to take on distribution and existing inventory for Burberry and Lanvin fragrances once its distribution deal with Procter & Gamble expires Dec. 31 (1"The Rose Sheet" Sept. 13, 2010). In the third quarter, the company experienced shortfalls in inventory, and as a result, certain shipments that were planned for the period are expected to ship in the fourth quarter, the firm said

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017281

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel